Filing Flows › Viemed Healthcare (VMD) › Guidance & outlook
Viemed Healthcare (VMD) guidance and outlook
Viemed Healthcare's 10-Q filed Nov 4, 2026 makes 10 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 4, 2026
- We will continue to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K with the SEC and with the relevant Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval (SEDAR).
- We expect to grow through expansion of existing service areas as well as in new territories through a cost efficient launch that reduces location expenses.
- We expect to expand our workforce of licensed clinical practitioners, including RTs, to support our growth and ensure the high service model is maintained in the home.
- By focusing overhead costs on personnel that service the patient rather than physical location costs, we anticipate that we will efficiently scale our business in territories that are currently not being effectively serviced.
- The continued trend of servicing patients in the home rather than in hospitals is aligned with our business objective and we anticipate that this trend will continue to offer growth opportunities for us.
- We expect to continue to be a solution to the rising health costs in the United States by offering more cost effective, home based solutions while increasing the quality of life for patients managing chronic and complex health conditions.
- We expect research and development costs to remain consistent throughout the remainder of 2026 as we continue to invest in technology initiatives to support our clinical operations and service delivery capabilities.
- The ventilator buyback program was substantially completed in 2025, and accordingly we do not expect additional material gains from these transactions in future periods.
- We expect to refinance or replace the facilities prior to maturity; however, there can be no assurance that replacement financing will be available on acceptable terms.
- Except for the funding of potential acquisitions and investments, we anticipate that our operating cash flows will satisfy our material cash requirements for the 12 months after September 30, 2026.
Viemed Healthcare's latest quarter
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What does Viemed Healthcare expect?
We will continue to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K with the SEC and with the relevant Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval (SEDAR). We expect to grow through expansion of existing service areas as well as in new territories through a cost efficient launch that reduces location expenses. We expect to expand our workforce of licensed clinical practitioners, including RTs, to support our growth and ensure the high service model is maintained in the home.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.